Reports and Articles
Center for Technology Innovation at Brookings Report
The Adverse Impact of the US Reimbursement System on the Development and Adoption of Personalized Medicine Diagnostics
Personalized Medicine Coalition (PMC) Report
Genome Canada, Policy Brief
The OECD is a unique forum where the governments of 30 democracies work together
to address the economic, social and environmental challenges of globalisation. This OECD Report reviews the use of pharmacogenetics across all stages of the health innovation cycle from research through to uptake by doctors and patients. It focuses on how to optimise the use of pharmacogenetics to deliver effective innovations for public health, and design policies that enhance their economic and social benefits.
Published by the Personalized Medicine Coalition, this report details how personalized medicine plays an increasingly integral role in delivering high-quality, cost-effective health care and presents evidence that personalized medicine will continue to grow in importance as scientific breakthroughs are translated into a new generation of targeted therapeutics.
Ensuring Access to High Quality Molecular Oncology Laboratory Testing and Clinical Cancer Genetic Services in Ontario
Ontario Ministry of Health and Long-Term Care, Molecular Oncology Task Force Report
President’s Council of Advisors on Science and Technology (PCAST) Report